Children living in higher-income communities were 55% more likely to be prescribed the medicines, suggesting emerging disparities in access, according to the study
The use of GLP-1 drugs to treat obesity in children aged 8–11 in the United States has grown rapidly.
A study published on September 4, 2026 in the journal Pediatrics analyzed electronic health records of more than 3.5 million children with obesity and without diabetes, Reuters reports.
According to......